Our 2013 acquisition of Partners Rx has enabled  us to expand our capabilities and competitive advantage. Magellan Rx Management has broad- ened its scale to reach new customer markets,  especially those within the commercial middle  market segment whose needs are largely unmet  by today’s PBMs.  Our collective organization is applying our vast pharmacy expertise to employ market-leading  technologies that drive superior service and clinical management. In so doing, we are able to help demystify the complexities of pharmacy  benefit management and lower costs  , agellan 1 W , anagement offers a wide product  spectrum that includes pharmacy benefit  management, pharmacy benefit administration,  and specialty and medical pharmacy management.  6 ith this product suite, we can drive eƧ ciencies,  innovate new product offerings and manage total  drug spend on behalf of customers. A hallmark of Magellan’s business philosophy has been to build partnerships with our customers.  We take the time to understand our customers’  business challenges and work together to solve  them. Then, we track our results and performance  through precise data analytics and apply that  knowledge to refine our models for the benefit of  our customers. Nowhere is this more important  than in the highly complex, high-cost environment  of pharmacy benefit management Magellan Rx Management has the expertise to  provide proven cost-savings options, the knowledge for better decision making, and a partnership culture that uniquely adapts to customers’ needs – all with the precision and performance that one  expects from an industry leader. 2013 Annual Report 9